Roper Technologies, Inc. - Common Stock (ROP)
Healthcare › Industrial Instruments For Measurement, Display, and Control
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 25% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 8.6% — below-average profitability
- Revenue growing at 12% annually
Roper Technologies, Inc. - Common Stock (ROP) is a Healthcare company operating in Industrial Instruments For Measurement, Display, and Control, listed on the NASDAQ , with a market capitalisation of $32.8 billion . Key value metrics: P/E ratio 20.3, P/B ratio 1.74, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Roper Technologies, Inc. - Common Stock — Fundamental Analysis Summary
Roper Technologies, Inc. - Common Stock (ROP) is currently trading 25% above its Graham Number of $259.26, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 20.3x.
On financial health, ROP shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 8.6% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.52.
StockPik's composite Value Score for ROP is 61/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ROP reports a high gross margin of 69.2% (sector average: 39.4%) and a strong operating margin of 27.9%.
ROP shows revenue growing at 12% year-over-year, with earnings declining at 1%.
ROP pays a modest dividend yield of 1.0%.